Nomura Asset Management CO LTD Janux Therapeutics, Inc. Transaction History
Nomura Asset Management CO LTD
- $35.5 Billion
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JANX
# of Institutions
187Shares Held
56MCall Options Held
869KPut Options Held
652K-
Ra Capital Management, L.P. Boston, MA11.2MShares$319 Million5.65% of portfolio
-
Janus Henderson Group PLC London, X04.46MShares$127 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.92MShares$83.3 Million3.15% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.53MShares$72 Million0.1% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$66.8 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.19B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...